News

Young nephrologists: Apply by April 23 for the chance to win free registration to the 44th Vincenza Course  

The  44th Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology 2026 will take place from June 16-18, 2026, at the Vicenza International Convention Centre in Vicenza, Italy.   This hands-on course for beginner and advanced kidney care professionals explores the latest advances in acute kidney injury, from diagnosis and treatment strategies to emerging therapies to help prevent progression to chronic kidney disease.  Explore the preliminary scientific...

What do kidneys actually do? Make sure your patients know! 

The ISN “Are your kidneys healthy?” quiz webpage has been refreshed with a new design that makes key kidney health information easier to explore.  Access the “Are your kidneys healthy?” quiz  Available in 35 languages, the quiz helps better understand kidney function, risk factors, and steps they can take to protect their kidney health.   Share the quiz with your patients to open a dialogue about...

ISN global engagement: Supporting kidney care in Bangladesh and the Philippines this April 

The ISN continues to support the advancement of kidney care through engagement, most recently with nephrology communities in Bangladesh and the Philippines in April, strengthening collaboration, education, and knowledge exchange across regions. 8th International Conference of Paediatric Nephrology Society of Bangladesh April 11-12, 2026 Dhaka, Bangladesh ISN President Marcello Tonelli’s pre-recorded welcome message will be played at...

Healing in Harmony: Moving story of the Aurenis Choir wins ISN Community Film Award 

The winning film* of the ISN Community Film Event, “Aurenis Choir: A Song of Hope” is a moving story from Argentina that reminds us that kidney care is not only about medicine, but also about connection, creativity, and hope.  The Aurenis Choir was founded on World Kidney Day 2024 with the aim of creating a space for community, art, and meaning alongside...

ISN Journal summaries on modern challenges in infection prevention & CKD in migrants 

Kidney International®   Modern challenges in infection prevention: encapsulated organisms in the era of novel complement inhibitors  This mini review examines infection prevention in patients receiving novel complement inhibitors, with a focus on serious infections caused by encapsulated organisms.   It outlines practical strategies, including vaccination, antibiotic prophylaxis, and patient education.   The authors stress that these therapies offer important benefits...

Maximize workforce potential in your community: insights from ISN ELP cohort 3 

Featured in the March edition of Kidney International Reports®, the ISN Emerging Leaders Program (ELP) cohort 3 article, “Expanding kidney care: How non-physician health workers can address the global CKD crisis,” explores how non-physician healthcare professionals can help strengthen chronic kidney disease detection, referral, and care beyond specialist settings.  Read the paper  At WCN’26, cohort 3 members will take this conversation further through examples from India, Fiji, Nigeria,...

A new IgAN curriculum for current clinical practice

The ISN’s new IgA Nephropathy Curriculum delivers timely, practice-focused insights to help you integrate emerging evidence into care and optimize outcomes. Access the curriculum at the ISN Academy The curriculum is organized into three core areas of IgAN: pathogenesis, treatment, and prediction. Each section features in-depth conversations with David Wheeler, Jonathan Barret, and Michelle O'Shaughnessy, conducted...

Help shape sustainable kidney care: Contribute to the GREEN-K procurement strategy 

                      The ISN-led GREEN-K* (Global Environmental Evolution in Nephrology and Kidney Care) initiative invites the global kidney community to review and comment on a joint draft statement, “Procurement for Environmentally and Ethically Sound Kidney Care Products and Services.”  Read the draft statement and share your feedback by...

ISN Journal summaries on sefaxersen for IgAN and the effect of climate change on kidney disease 

Kidney International®   A single-arm phase 2 trial of an investigational RNA therapeutic targeting complement factor B (sefaxersen) for treatment of IgA nephropathy  IgA nephropathy (IgAN) involves activation of the complement alternative pathway, contributing to kidney inflammation and disease progression.   In this global, open-label phase 2 trial, patients with biopsy-confirmed IgAN received sefaxersen, an antisense inhibitor of complement factor B, to...

Kintsugi and kidney care: Young nephrologists in Japan share insights ahead of WCN’26 

In Japan, the art of kintsugi repairs broken pottery with adhesive and powdered gold, transforming fracture into renewed strength.   As the global kidney care community prepares to gather in Yokohama for WCN’26, Japan’s approach to kidney health offers a compelling parallel: working with impairment to preserve function, extending quality of life in an aging society, and continuously strengthening systems of care through early detection and...

A transformative experience“: Apply for an ISN Interventional Nephrology Scholarship 

Ready to advance your interventional nephrology (IN) skills? ISN IN Scholarships offer hands-on training and structured mentorship to help you strengthen procedural practice in your home institution.  Learn more about ISN Interventional Nephrology Scholarships and apply  For ISN IN scholar Odalina Marrero, the scholarship addressed pressing needs in her home country, the Dominican Republic, where kidney care is advancing but access to specialized procedures remains limited...

Apply by March 23 to attend the ISN Primer Course in Glomerular Diseases in Uruguay 

Looking to strengthen your confidence in diagnosing and managing glomerular diseases? The ISN Primer Course in Glomerular Diseases offers an intensive, case-based learning experience designed to sharpen clinical decision-making and connect you with international faculty and peers.  Applications are now open for the next edition of the course in Montevideo, Uruguay, from August 8–9, 2026.  Find...

Notice of ISN General Assembly at WCN’26 – Register by March 24

The ISN General Assembly meeting will take place in person in Yokohama, Japan during the ISN World Congress of Nephrology (March 28-31, 2026), as follows: 7:45 - 8:45 a.m. Japan Standard Time (JST) Please arrive by 7:30 a.m., so we can ensure the meeting is attended by ISN voting members Tuesday, March 31, 2026 Pacifico Yokohama Room 315 level...

ISN across continents: Advancing kidney care through global engagement 

From Africa to East Asia, ISN leaders are engaging with regional kidney care communities this March, sharing expertise, training opportunities, and strengthening connections that help advance equitable kidney care worldwide.  Ethiopian Kidney Association’s 2nd Annual Nephrology Conference  March 7, 2026 Addis Ababa, Ethiopia  Robert Walker, chair of the ISN Core Programs Committee, will present virtually on ISN Grants, outlining pathways for ISN members to access support and build local capacity.  Japan Kidney Masterclass  March 7, 2026 Tokyo, Japan  Hosted by the Japanese Society of Nephrology, the masterclass will...

Turn your research idea into impact: Apply by March 1 to the ISN Clinical Research Program 

Do you have a clinical research question on how to improve kidney care in your region? The ISN Clinical Research Program (CRP) helps clinicians turn local priorities into publishable evidence, providing funding and support to launch meaningful studies.  Applicants must submit a short abstract to the relevant ISN Regional Coordinator by March 1.   Find out more and apply  Rumbidzai Dahwa received a CRP grant in 2017 to study the prevalence...

Experience WCN’26 wherever you are: Join virtually 

Virtual registration brings the World Congress of Nephrology 2026 straight to you, no matter where you are.   As a virtual delegate, you get access to live streaming of all 13 sessions in the Main Hall (Plenary Hall) from March 28–31, with live transcriptions in Japanese and English and more than 50 other languages. You will also have access to over 100 hours of...

Sharing bedside lessons: Writing a case report for Kidney International Case Reports™ 

Every nephrologist has encountered a case that stayed with them, one that challenged assumptions, raised new questions, or changed how they approach care. Turning that experience into a case report is not about including every detail, but about sharing the clinical lesson that others can apply.  Submit your case report to KICR  Kidney International Case Reports™...

Training that transforms kidney care: Welcoming new ISN Fellows 

For many nephrologists, an ISN Fellowship is more than advanced training; it is a turning point in what becomes possible for patients and kidney care teams back home.  “The ISN Fellowship program represented a pivotal moment in my professional journey,” reflects Christina Amira (Nigeria), ISN Fellow from 2003–2004. “Upon returning to my home country, I successfully established a...

World Kidney Day 2026: Caring for people, protecting the planet — get involved! 

How will you support kidney health and sustainability this World Kidney Day?  With kidney disease affecting millions worldwide and environmental factors such as heat, pollution, and access to clean water increasingly shaping risk, this year’s theme, “Kidney Health for All: Caring for People, Protecting the Planet,” calls for prevention, early detection, and care models that are people-centered and planet-conscious.  Read...

ISN Journal summaries: effect of pravastatin on ADPKD and 10 years of Kidney International Reports®   

Kidney International®   A randomized controlled trial evaluated the effect of pravastatin on kidney disease outcomes in adult patients with early-stage autosomal dominant polycystic kidney disease  This randomized, double-blind trial evaluated whether pravastatin could slow disease progression in adults with early autosomal dominant polycystic kidney disease (ADPKD) and preserved kidney function.   Researchers followed 150 participants receiving pravastatin or a placebo...